As of June 2026, MDT's current EPS stands at $3.75, according to the latest financial reports. For the year 2026, the company recorded an earnings per share (EPS) of $3.75, which marks an increase compared to its EPS of $3.63 in 2025. MDT reported an EPS of $0.98 for the quarterly report ending on Apr 24, 2026.
For 2026, Medtronic's EPS was $3.75, an increase of 3.3% from $3.63 in 2025. For the fiscal quarter that ended on Apr 24, 2026, the per-share earnings was $0.98, showing a 18.1% increase from the same quarter last year. For the twelve months ending April 2026, the EPS is $3.75. For the year 2025, the yearly earnings per share was $3.63, marking an increase of 31% from 2024.
Medtronic has registered an increase in EPS of 18.1% during the last 12 months (YoY, quarterly). In the last three years, MDT recorded an average annual EPS growth rate of 9.8%. Medtronic had an average annual EPS growth rate of 6.9% during the last 5 years. Across the last decade, MDT had an average annual EPS growth of 4.1%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| BSX Boston Scientific Corp | 18.65 | 55.6% | 63.3% | N/A |
| CNMD CONMED Corp | 18.84 | -64.6% | N/A | 35.7% |
| MDT Medtronic plc | 21.4 | 3.3% | 9.8% | 6.9% |
| ABT Abbott Laboratories | 25.11 | -51.4% | -1.8% | 8.2% |
| JNJ Johnson & Johnson | 26.95 | 90.6% | 17.7% | 14.8% |
| SYK Stryker Corp | 35.31 | 8% | 10.9% | 14.8% |
| EW Edwards Lifesciences Corp | 45.63 | -73.6% | -9.2% | 6.9% |
| BAX Baxter International Inc | N/A | -47.2% | N/A | N/A |
| ACH Accendra Health Inc. | N/A | -202.5% | N/A | N/A |
| IART Integra Lifesciences Holdings Corp | N/A | -7,388.9% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.